Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial
Clinical trial NCT02951637 · UNKNOWN
Trial details
- NCT number
- NCT02951637
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-04-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.